W Stephen Holmes's Net Worth

$398 Million

Who is W Stephen Holmes?

W Stephen Holmes has an estimated net worth of $398 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, ANESIVA, INC., INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, MACROGENICS INC, Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics Inc, APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, EPOCRATES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.

SEC CIK

W Stephen Holmes's CIK is 0001293923

Past Insider Trading and Trends

2014 was W Stephen Holmes's most active year for acquiring shares with 35 total transactions. W Stephen Holmes's most active month to acquire stocks was the month of May. 2014 was W Stephen Holmes's most active year for disposing of shares, totalling 32 transactions. W Stephen Holmes's most active month to dispose stocks was the month of April. 2007 saw W Stephen Holmes paying a total of $9,500,001.45 for 3,522,070 shares, this is the most they've acquired in one year. In 2013 W Stephen Holmes cashed out on 40,772,948 shares for a total of $70,818,664.12, their largest year based on trade value.